This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Turnstone Biologics Inc. (developing oncolytic virus-based therapies for cancer) raised $11.3mm through its Series A round led by Versant Ventures. Founding investor FACIT (Fight Against Cancer Innovation Trust; established by the Ontario Institute for Cancer Research) also participated. Versant takes two board seats.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?